The HPLC market is expected to reach $7.9 billion by 2030, at a CAGR of 5.2% from 2023 to 2030.
After extensive primary and secondary research, the report provides an in-depth analysis of the HPLC market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the HPLC market. The growth of the HPLC market is driven by the increasing R&D investments in the pharmaceutical and biotechnology industries, technological advancements in HPLC, rising food safety concerns, and stringent policies and initiatives to reduce environmental pollution. However, the high costs of HPLC Instruments restrain this market's growth to a significant extent.
Emerging economies and the development of bio-clusters to foster research offers opportunities for market growth. However, the shortage of skilled HPLC professionals and the adoption of refurbished HPLC instruments are the major challenges to the market’s growth.
Among the products, in 2023, the HPLC systems segment is estimated to account for the largest share of the HPLC market. The large market share of this segment is attributed to technological advancements, automation, and miniaturization of instruments, increasing their usage for various applications such as drug development and discovery, food testing and labeling, and environmental testing.
Among the end users, in 2023, the pharmaceutical & biopharmaceutical companies segment is estimated to account for the largest share of the HPLC market. The large market share of this segment is attributed to the increased number of research studies covering biologics and biosimilars, increased production of drug molecules, and growing collaborations among pharmaceutical & biotechnology companies and CROs.
An in-depth analysis of the geographical scenario of the HPLC market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the HPLC market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s major market share is attributed to the rising prevalence of chronic diseases and the need for novel therapies, the increase in venture capital funding for the biopharmaceutical sector, and the presence of key companies in the region.
The key players operating in the HPLC market are Waters Corporation (U.S.), Shimadzu Corporation (Japan), Danaher Corporation (U.S.), Bruker Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sartorius AG (Germany), Gilson, Inc. (U.S.), Tosoh Corporation (Japan), Hitachi, Ltd. (Japan), and JASCO Corporation (Japan).
2. Other components & accessories include injectors, degassers, column ovens, mixers, plungers, reducers, valves, adapters, connectors, injection needles, valve seals, frits, plungers, and cartridges.
After extensive primary and secondary research, the report provides an in-depth analysis of the HPLC market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the HPLC market. The growth of the HPLC market is driven by the increasing R&D investments in the pharmaceutical and biotechnology industries, technological advancements in HPLC, rising food safety concerns, and stringent policies and initiatives to reduce environmental pollution. However, the high costs of HPLC Instruments restrain this market's growth to a significant extent.
Emerging economies and the development of bio-clusters to foster research offers opportunities for market growth. However, the shortage of skilled HPLC professionals and the adoption of refurbished HPLC instruments are the major challenges to the market’s growth.
Among the products, in 2023, the HPLC systems segment is estimated to account for the largest share of the HPLC market. The large market share of this segment is attributed to technological advancements, automation, and miniaturization of instruments, increasing their usage for various applications such as drug development and discovery, food testing and labeling, and environmental testing.
Among the end users, in 2023, the pharmaceutical & biopharmaceutical companies segment is estimated to account for the largest share of the HPLC market. The large market share of this segment is attributed to the increased number of research studies covering biologics and biosimilars, increased production of drug molecules, and growing collaborations among pharmaceutical & biotechnology companies and CROs.
An in-depth analysis of the geographical scenario of the HPLC market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the HPLC market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s major market share is attributed to the rising prevalence of chronic diseases and the need for novel therapies, the increase in venture capital funding for the biopharmaceutical sector, and the presence of key companies in the region.
The key players operating in the HPLC market are Waters Corporation (U.S.), Shimadzu Corporation (Japan), Danaher Corporation (U.S.), Bruker Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sartorius AG (Germany), Gilson, Inc. (U.S.), Tosoh Corporation (Japan), Hitachi, Ltd. (Japan), and JASCO Corporation (Japan).
Scope of the Report:
High-performance Liquid Chromatography Market Assessment - by Product
- HPLC Systems
- Consumables
- Columns
- Pre-packed Columns
- Empty Columns
- Reagents & Buffers
- Vials
- Fittings & Tubing
- Syringe Filters
- Well Plates
- Other Consumables
- Components & Accessories
- Detectors & Lamps
- Pumps
- Fraction Collectors
- Other Components & Accessories
- Software & Services
2. Other components & accessories include injectors, degassers, column ovens, mixers, plungers, reducers, valves, adapters, connectors, injection needles, valve seals, frits, plungers, and cartridges.
High-performance Liquid Chromatography Market Assessment - by End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Food & Beverage Companies
- Environmental Testing Laboratories
- Hospitals & Clinics
- Oil & Gas Industries
- Other End Users
High-performance Liquid Chromatography Market Assessment - by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Table of Contents
1. Introduction
2. Research Methodology
4. Market Insights
5. High-Performance Liquid Chromatography (HPLC) Market Assessment - by Product
6. High-Performance Liquid Chromatography (HPLC) Market Assessment - by End User
7. High-Performance Liquid Chromatography (HPLC) Market Assessment - by Geography
8. Competitive Landscape
9. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)
10. Appendix
List of Tables
List of Figures
Companies Mentioned
- Waters Corporation
- Shimadzu Corporation
- Danaher Corporation
- Bruker Corporation
- Merck KGaA
- Agilent Technologies Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Sartorius AG
- Gilson Inc.
- Tosoh Corporation
- Hitachi Ltd.
- JASCO Corporation
